TNFSF11 and fibrosis: Tissue staining revealed that silica-dependent pulmonary inflammation and fibrosis were significantly attenuated by 5 weeks of anti-RANKL antibody treatment as compared to Ctrl IgG treatment based on Ashcroft scoring and examination of tissue sections (Fig. 7, E and F, and fig.